Possibilities of using beta-blockers in the therapy of portal hypertension in dogs caused by liver cirrhosis

被引：0
|
作者：
Glinska, K [1 ]
Nicpon, J [1 ]
Wrzosek, M [1 ]
Kungl, K [1 ]
机构：
[1] AR, Wydzial Med Weterynaryjnej, Katedra Chorob Wewnetrznych & Pasozytniczych, Klin Chorob Koni Psow & Kotow, PL-50366 Wroclaw, Poland
来源：
MEDYCYNA WETERYNARYJNA | 2005年 / 61卷 / 07期
关键词：
portal hypertension; liver cirrhosis; dog;
D O I：
暂无
中图分类号：
S85 [动物医学（兽医学）];
学科分类号：
0906 ;
摘要：
Liver cirrhosis is a disease common in veterinary gastroenterology. Advanced liver cirrhosis leads to hemodynamic disorders and the onset of portal hypertension. The article presents the possibilities of using non-selective adrenolitics that inhibit both beta I and beta 2 adrenergic receptors (propranolol) in the treatment of portal hypertension in dogs with liver cirrhosis.
引用
收藏
页码：739 / 741
页数：3
相关论文
共 50 条
  • [31] Treatment of portal hypertensia by beta-blockers and ACE-inhibitors in patients sick of cirrhosis and arterial hypertension
    Miheeva, Olga
    Lazebnik, Leonid
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 137 : S85 - S86
  • [32] The use of Beta-Blockers in Patients With Liver Cirrhosis Undergoing Liver Transplantation
    Josefsson, Axel
    Fu, Michael
    Bjornsson, Einar
    Olausson, Michael
    Kalaitzakis, Evangelos
    GASTROENTEROLOGY, 2010, 138 (05) : S821 - S821
  • [33] β-blockers for cirrhosis and portal hypertension
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (06): : 422 - 422
  • [34] ELECTRIC AND HEMODYNAMIC EFFECTS OF BETA-BLOCKERS IN PATIENTS WITH LIVER CIRRHOSIS
    Tieranu, Eugen
    Donoiu, Ionut
    Istratoaie, Octavian
    Tieranu, Loredana Maria
    Gheonea, Dan-Ionut
    Ciurea, Tudorel
    Ghenea, Alice Elena
    Ungureanu, Anca
    FARMACIA, 2020, 68 (05) : 843 - 848
  • [35] Letter: nonselective beta-blockers, endoscopic therapy and portal vein thrombosis in cirrhosis. Authors' reply
    Nery, Filipe
    Valla, Dominique
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (10) : 1371 - 1372
  • [36] PROGNOSTIC VALUE OF SECONDARY HYPERALDOSTERONISM IN DEVELOPMENT OF RESISTANCE TO NONSELECTIVE BETA-BLOCKERS (BB) PORTAL HYPERTENSION (PH) WITH CIRRHOSIS
    Fedulenkova, L.
    Drozdov, V.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S215 - S215
  • [37] Hemodynamic response to beta-blockers for portal hypertension: A single center experience
    Tiani, C.
    Berzigotti, A.
    Vizioli, L.
    Zorzi, V.
    Magalotti, D.
    Zoli, M.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 : S93 - S93
  • [38] PORTAL SYSTEMIC ENCEPHALOPATHY DURING BETA-BLOCKERS ADMINISTRATION IN PATIENTS WITH ADVANCED LIVER-DISEASE AND PORTAL-HYPERTENSION
    URIBE, M
    BALLESTEROS, A
    RAMOS, M
    VARGAS, F
    GUEVARA, L
    HEPATOLOGY, 1984, 4 (04) : 752 - 752
  • [39] Beta-Blockers and Hypertension Reply
    Messerli, Franz H.
    Bangalore, Sripal
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (22) : 2106 - 2107
  • [40] BETA-BLOCKERS FOR PREGNANCY HYPERTENSION
    SMITH, AM
    LANCET, 1983, 1 (8326): : 708 - 709
12345